Enhanced Safety Surveillance of GSK’s Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany, and Spain for the 2018/19 Season: Interim Analysis-Reference-Cited by-同舟云学术

Enhanced Safety Surveillance of GSK’s Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany, and Spain for the 2018/19 Season: Interim Analysis

Published:2019-10-08 Issue:12 Volume:36 Page:3340-3355
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Dos Santos Gael,Shende Vishvesh,Damaso Silvia,Yeakey Anne

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12325-019-01105-2.pdf

Reference17 articles.

1. Cassini A, Colzani E, Pini A, et al. Impact of infectious diseases on population health using incidence-based disability-adjusted life years (DALYs): results from the Burden of Communicable Diseases in Europe study, European Union and European Economic Area countries, 2009 to 2013. Euro Surveill. 2018;23(16).

2. World Health Organisation (WHO). Fact Sheets. Influenza (seasonal). http://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal ). Accessed 1 Apr 2019.

3. World Health Organization (WHO). Influenza vaccines. http://www.who.int/influenza/vaccines/en/ . Accessed 1 Apr 2019.

4. European Medicines Agency (EMA). Interim guidance on enhanced safety surveillance for seasonal influenza vaccines in the EU 2014. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2014/04/WC500165492.pdf . Accessed 1 Apr 2019.

5. European Medicines Agency (EMA). Explanatory note on the withdrawal of the Note for guidance on harmonisation of requirements for influenza vaccines and of the core SmPC/PL for inactivated seasonal influenza vaccines. 2014. https://www.ema.europa.eu/en/documents/scientific-guideline/explanatory-note-withdrawal-note-guidance-harmonisation-requirements-influenza-vaccines-core-summary_en-0.pdf . Accessed 1 Apr 2019.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An 8-Year Prospective, Observational, Multi-centre Post-Marketing Safety Surveillance Study Conducted in South Korea (2014–2022) Following the Introduction of GSK’s Inactivated Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) for Subjects Aged 6 Months and Older;Drug Safety;2024-03-14

2. Hemagglutinin-based DNA vaccines containing trimeric self-assembling nanoparticles confer protection against influenza;Journal of Leukocyte Biology;2022-01-17

3. Brand-Specific Enhanced Safety Surveillance Study of GSK’s Quadrivalent Seasonal Influenza Vaccine, Conducted During the COVID-19 Pandemic, in Belgium, Germany and Spain, for the 2020/21 Season;Infectious Diseases and Therapy;2021-12-27

4. Expert opinion on the way forward for improving maternal influenza vaccination in India;Expert Review of Vaccines;2021-05-31

5. Brand-Specific Enhanced Safety Surveillance of GSK’s Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain for the 2018/2019 Season;Drug Safety;2019-12-28